Your browser doesn't support javascript.
loading
Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial.
Chen, Alice P; Kummar, Shivaani; Moore, Nancy; Rubinstein, Lawrence V; Zhao, Yingdong; Williams, P Mickey; Palmisano, Alida; Sims, David; O'Sullivan Coyne, Geraldine; Rosenberger, Christina L; Simpson, Mel; Raghav, Kanwal P S; Meric-Bernstam, Funda; Leong, Stephen; Waqar, Saiama; Foster, Jared C; Konaté, Mariam M; Das, Biswajit; Karlovich, Chris; Lih, Chih-Jian; Polley, Eric; Simon, Richard; Li, Ming-Chung; Piekarz, Richard; Doroshow, James H.
Afiliación
  • Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Moore N; Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Zhao Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Williams PM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Palmisano A; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Sims D; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • O'Sullivan Coyne G; General Dynamics Information Technology (GDIT), Falls Church, VA.
  • Rosenberger CL; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Simpson M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Raghav KPS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Meric-Bernstam F; Applied/Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Leong S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Waqar S; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Foster JC; University of Colorado Cancer Center, Aurora, CO.
  • Konaté MM; Department of Medical Oncology, Washington University School of Medicine, St Louis, MO.
  • Das B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Karlovich C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Lih CJ; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Polley E; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Simon R; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD.
  • Li MC; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
  • Piekarz R; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
  • Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
Article en En | MEDLINE | ID: mdl-33928209

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JCO Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Moldova

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JCO Precis Oncol Año: 2021 Tipo del documento: Article País de afiliación: Moldova